Stem Cells / Regenerative Medicines
BPE Innovation works closely with the major players in the public and private sectors within the UK in stem cell research. As such it is able to advise on areas such as human embryonic stem cell research, embryonic Stem (ES) Cells, cord blood and placental stem cells, foetal stem cells and adult stem cells. Advice on the Human Fertilisation and Embryology Act 1990 and the Human Fertilisation and Embryology (Research Purposes) Regulations 2001 and the Human Reproductive Cloning Act 2001 can be provided.
BPE's range of services dedicated to regenerative medicines, in particular stem cell research, includes: